 4. Have adequate bone marrow function defined as an absolute peripheral granulocyte count of 1,000mm3 and platelet count of 140,000mm3; hemoglobin 9.0 gdL without transfusion or growth factor support, unless the patient is 6 weeks from last cancer therapy in which case transfusion is allowed. 